Do Peptides Work? A Data-Driven Analysis of Efficacy, Market Trends, and Brand Comparisons
Abstract: This data-driven analysis evaluates peptide efficacy through clinical studies (e.g., 78% improvement in collagen synthesis per J Cosmet Dermatol ). Market trends project a CAGR of 8.9% (2024-2030), driven by anti-aging and therapeutic applications. Brand comparisons reveal Cu-GHK (copper peptide) outperforms Matrixyl 3000 in wound healing (p<0.05). Technical trade-offs include stability vs. bioavailability. Selection criteria prioritize GMP-certified manufacturers (ISO 22716) and third-party purity assays (>98%). Logistics require cold-chain compliance (2-8°C) to maintain potency. Industry insights highlight regulatory gaps in cosmetic vs. pharmaceutical peptides.